z-logo
Premium
Strategies to Improve Cancer Photothermal Therapy Mediated by Nanomaterials
Author(s) -
de MeloDiogo Duarte,
PaisSilva Cleide,
Dias Diana R.,
Moreira André F.,
Correia Ilídio J.
Publication year - 2017
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201700073
Subject(s) - photothermal therapy , cancer therapy , nanomaterials , nanotechnology , cancer , materials science , medicine
The deployment of hyperthermia‐based treatments for cancer therapy has captured the attention of different researchers worldwide. In particular, the application of light‐responsive nanomaterials to mediate hyperthermia has revealed promising results in several pre‐clinical assays. Unlike conventional therapies, these nanostructures can display a preferential tumor accumulation and thus mediate, upon irradiation with near‐infrared light, a selective hyperthermic effect with temporal resolution. Different types of nanomaterials such as those based on gold, carbon, copper, molybdenum, tungsten, iron, palladium and conjugated polymers have been used for this photothermal modality. This progress report summarizes the different strategies that have been applied so far for increasing the efficacy of the photothermal therapeutic effect mediated by nanomaterials, namely those that improve the accumulation of nanomaterials in tumors (e.g. by changing the corona composition or through the functionalization with targeting ligands), increase nanomaterials' intrinsic capacity to generate photoinduced heat (e.g. by synthesizing new nanomaterials or assembling nanostructures) or by optimizing the parameters related to the laser light used in the irradiation process (e.g. by modulating the radiation wavelength). Overall, the development of new strategies or the optimization and combination of the existing ones will surely give a major contribution for the application of nanomaterials in cancer PTT.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here